Abstract
Introduction
Oxidative stress induced by reactive oxygen species (ROS) is associated with the risk of osteoporosis, and can be reduced by certain dietary antioxidants. Lycopene is an antioxidant known to decrease the risk of age-related chronic diseases, such as cancer. However, the role of lycopene in osteoporosis has not yet been investigated.
Materials and methods
In a cross-sectional study, 33 postmenopausal women aged 50–60 years provided seven-day dietary records and blood samples. Serum samples were used to measure serum lycopene, lipid peroxidation, protein thiols, bone alkaline phosphatase (BAP), and cross-linked N-telopeptides of type I collagen (NTx). The serum lycopene per kilogram body weight of the participants was grouped into quartiles and associated with the above serum parameters using one-way ANOVA and the Newman-Keuls post-test.
Results
The results showed that groups with higher lycopene intake, as determined from the dietary records, had higher serum lycopene (p<0.02). A higher serum lycopene was found to be associated with a low NTx (p<0.005). Similarly, groups with higher serum lycopene had lower protein oxidation (p<0.05).
Discussion
In conclusion, these results suggest that the dietary antioxidant lycopene reduces oxidative stress and the levels of bone turnover markers in postmenopausal women, and may be beneficial in reducing the risk of osteoporosis.
Similar content being viewed by others
References
World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD (1996) Markers of bone resorption predict hip fracture risk in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11(10):1531–1538
de Vernejoul M-C (1998) Markers of bone remodeling in metabolic bone disease. Drugs Aging 12(Suppl 1):9–14
Kushida K, Takahashi M, Kawana K, Inoue T (1995) Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab 80(8):2447–2450
Beers MH, Berkow RB (eds) (1999) The Merck manual of diagnosis and therapy. Merck Research Laboratories, Whitehouse Station, New Jersey
Fischer M, Raue F (1999) Measurements of bone mineral density. Mineral density in metabolic bone disease. Q J Nucl Med 43(3):233–240
Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288(1):275–279
Melhus H, Michaelsson K, Holmberg L, Wolk A, Jungall L (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14(1):129–135
Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88(4):1523–1527
Rao L, Krishnadev N, Banasikowska K, Rao A (2003) Lycopene I—effect of osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures. J Med Food 6(2):69–78
Kim L, Rao AV, Rao LG (2003) Lycopene II—effect on osteoblasts: the carotenoid lycopene stimulates cell proliferation and alkaline phosphatase activity of SaOS-2 cells. J Med Food 6(2):79–86
Park CK, Ishimi Y, Ohmura M, Yamaguchi M, Ikegami S (1997) Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J Nutr Sci and Vitaminol 43(3):281–296
Rao AV, Agarwal S (1999) Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res 19(2):305–323
Stahl W, Schwarz W, Sundquist AR, Sies H (1992) cis-trans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 294(1):173–177
Hu M (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:380–385
Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley MA (1993) Comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 15(4):353–363
Grolier P, Boirie Y, Levadoux E, Brandolini M, Borel P, Azais-Braesco V, Beaufrere B, Ritz P (2000) Age-related changes in plasma lycopene concentrations, but not in vitamin E, are associated with fat mass. Br J Nutr 84(5):711–716
Rock CL, Thornquist MD, Kristal AR, Patterson RE, Cooper DA, Neuhouser ML, Neumark-Sztainer D, Cheskin LJ (1999) Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: baseline results from the sentinel site of the Olestra Post-Marketing Surveillance Study. J Nutr 129(4):855–864
Mackinnon E, Rao A, Josse R, Murray T, Rao L (2006) Lycopene in the serum of postmenopausal women has interactive effects with the dietary components calcium and vitamin C on oxidative stress and bone turnover markers in international osteoporosis foundation world congress on osteoporosis. In: Proceedings of the International Osteoporosis Foundation World Congress on Osteoporosis, Toronto, Canada, June 2006
Zhang J, Munger RG, West NA, Cutler DR, Wengreen HJ, Corcoran CD (2006) Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status. Am J Epidemiol 163(1):9–17
Maggio D, Polidori CM, Barabani M, Tufi A, Ruggeiero C, Cecchetti R, Aisa MC, Stahl W, Cherubini A (2005) Low levels of carotenoids and retinol in involutional osteoporosis. Bone 38(2):244–248
Mayne ST, Cartmel B, Silva F, Kim CS, Fallon BG, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin WJ Jr (1999) Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentration and selected demographic factors. J Nutr 129(4):849–854
Casso D, White E, Patterson RE, Agurs-Collins T, Kooperburg C, Haines PS (2000) Correlates of serum lycopene in older women. Nutr Cancer 36(2):163–169
Dominguez Cabrera C, Sosa Henriquez M, Traba ML, Alvarez Villafane E, de la Piedra C (1998) Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporos Int 8(2):147–151
Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD (1996) Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women. Osteoporos Int 6(5):399–406
Sellmeyer DE, Schloetter M, Sebastian A (2002) Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab 87(5):2008–2012
Greenspan SL, Parker RA, Ferguson L, Rsen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13(9):1431–1438
Stepan JJ, Vokrouhlicka J (1999) Comparison of biochemical markers of bone remodelling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis. Clin Chim Acta 288(1–2):121–135
Rao AV (2004) Processed tomato products as a source of dietary lycopene: bioavailability and antioxidant properties. Can J Diet Pract Res 65(4):161–165
Hininger IA, Meyer-Wenger A, Moser U, Wright A, Southon S, Thurnham DI, Chopra M, Van den Berg H, Olmedilla B, Favier AE, Roussel AM (2001) No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr 20(3):232–238
Matos HR, Di Mascio P, Medeiros MHG (2000) Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch Biochem Biophys 383(1):56–59
Bhuvaneswari V, Velmurugan B, Abraham SK, Nagini S (2004) Tomato and garlic by gavage modulate 7,12-dimethylbenz[a]anthracene-induced genotoxicity and oxidative stress in mice. Braz J Med Biol Res 37(7):1029–1034
Rao AV, Agarwal S (1998) Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 31(3):199–203
Agarwal S, Rao AV (1998) Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33(10):981–984
O’Neill ME, Carroll Y, Corridan B, Olmedilla F, Granado F, Blanco I, Van den Berg H, Hininger IA, Rousell AM, Chopra M, Southon S, Thurnham DI (2001) A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr 85(4):499–507
Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS, Lewis CE, Nevitt MC, Simon JA, Stone KL, Wactawski-Wende J (2005) Lack of relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative. Am J Clin Nutr 82(3):581–588
Acknowledgments
Funding is shared by the Canadian Institutes of Health Research (CIHR) and the Research and Development Departments of Genuine Health Inc., the H.J. Heinz Co., Millenium Biologix Inc. (Canada), Kagome Co. (Japan), and LycoRed Natural Product Industries, Ltd. (Israel). We thank the assistance of Ms. H. Shen for the HPLC analysis, and Dr. C. Derzko and Mr. M. Simms for initial participant recruitment.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rao, L.G., Mackinnon, E.S., Josse, R.G. et al. Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos Int 18, 109–115 (2007). https://doi.org/10.1007/s00198-006-0205-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-006-0205-z